Skip to main content
. 2012 Aug 7;7(8):e41982. doi: 10.1371/journal.pone.0041982

Table 1. Hemodynamic and Hematologic Parameters.

PRE CPB AFTER CPB 1 HR AFTER CPB 3 HRS AFTER CPB 6 HRS AFTER CPB
TEMP
CONTROL 32.4+/−1.6 34.6+/−1.4 32.3+/−2.0 34.2+/−1.1 35.9+/−1.3
CO-TREATED 33.0+/−2.1 34.0+/−2.6 33.1+/−1.8 35.9+/−1.8 36.2+/−1.2
MAP (mm Hg)
CONTROL 55+/−10 74+/−14 66+/−6 65+/−8 60+/−10
CO-TREATED 54+/−8 71+/−13 62+/−6 59+/−4 58+/−4
pHa
CONTROL 7.49+/−0.10 7.36+/−0.11 7.43+/−0.04 7.45+/−0.06 7.43+/−0.06
CO-TREATED 7.50+/−0.06 7.40+/−0.06 7.40+/−0.04 7.44+/−0.06 7.42+/−0.08
PaO2 (mm Hg)
CONTROL 619+/−67 314+/−184 451+/−199 444+/−142 441+/−171
CO-TREATED 600+/−106 372+/−279 463+/−162 419+/−142 480+/−183
PaCO2 (mm Hg)
CONTROL 37.7+/−9.7 46.3+/−13.9 40.2+/−4.1 41.9+/−4.8 43.5+/−3.3
CO-TREATED 34.6+/−8.5 38.3+/−10.7 40.1+/−4.8 39.1+/−0.9 42.1+/−5.0
pHsss
CONTROL 7.42+/−0.08 7.30+/−0.10 7.34+/−0.01 7.38+/−0.04 7.35+/−0.06
CO-TREATED 7.43+/−0.05 7.36+/−0.03 7.31+/−0.05 7.35+/−0.06 7.38+/−0.03
PsssO2 (mm Hg)
CONTROL 44.1+/−11.8 50.6+/−10.5 37.9+/−6.6 46.3+/−8.8 47.4+/−15.8
CO-TREATED 45.3+/−13.4 43.4+/−18.6 44.3+/−9.9 39.3+/−9.9 43.4+/−12.2
PsssCO2 (mm Hg)
CONTROL 48.2+/−12.4 56.6+/−13.6 60.0+/−9.8 55.7+/−6.1 58.4+/−6.5
CO-TREATED 46.9+/−5.4 47.4+/−7.2 55.5+/−6.7 57.2+/−6.7 53.3+/−5.2
sss Saturation (%)
CONTROL 60+/−10 64+/−14 50+/−12 59+/−12 60+/−22
CO-TREATED 69+/−19 61+/−27 56+/−13 51+/−14 60+/−15
OER
CONTROL 70+/−6 53+/−11 66+/−18 62+/−14 63+/−16
CO-TREATED 63+/−10 58+/−18 65+/−10 66+/−14 67+/−11
HEMATOCRIT
CONTROL 35.2+/−4.5 36.7+/−5.8 34.7+/−5.6 35.3+/−8.1 34.2+/−7.6
CO-TREATED 37.3+/−8.3 38.2+/−4.3 35.7+/−2.4 37.8+/−5.0 33.0+/−4.2
Arterial Glucose
CONTROL 161+/−58 138+/−36 142+/−51 181+/−53 201+/−58
CO-TREATED 143+/−122 136+/−81 173+/−78 174+/−83 184+/−57
Arterial Lactate
CONTROL 4.0+/−2.8 9.9+/−4.3 7.4+/−1.7 5.2+/−1.7 4.6+/−3.9
CO-TREATED 3.5+/−1.3 8.2+/−1.3 7.5+/−0.9 5.7+/−1.8 5.4+/−1.7